Combination therapy with enalapril and hydrochlorothiazide: optimal dose, renin response, and prostaglandin excretion.
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D015237:Dinoprost; D015232:Dinoprostone; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage* / Q000494:pharmacology; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011453:Prostaglandins / Q000652:urine*; D011458:Prostaglandins E / Q000652:urine; D011460:Prostaglandins F / Q000652:urine; D011897:Random Allocation; D012083:Renin / Q000097:blood*
D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D006852:Hydrochlorothiazide; D015121:6-Ketoprostaglandin F1 alpha; D004656:Enalapril; D015237:Dinoprost; D012083:Renin; D015232:Dinoprostone